EUVIMEDEUVIMED entdecken
Crossref

Nanodrug Hijacking Blood Transferrin for Ferroptosis-Mediated Cancer Treatment

Shuyue Zhang, Xiao Wu, Xiaoming Liao, Shiyong Zhang iD

Journal of the American Chemical Society · 2024

DOI: 10.1021/jacs.4c00395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2024. Verfasst von Shuyue Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Biomedical Engineering and National Engineering Research Center for Biomaterials, Sichuan University, 610064 Chengdu, China. Hauptthemen laut MEDLINE: Ferroptosis, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Innovation Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis as a promising method of cancer treatment heavily relies on the intracellular iron ion level. Herein, a new iron-supplement nanodrug was developed by conjugating transferrin-homing peptide T10 on the surface of cross-linked lipoic acid vesicles (T10@cLAV), which could hijack blood transferrin (Tf) and specifically deliver it to tumor cells to elevate the Fe2+ level. Meanwhile, the intracellular degradation product of cLAV, dihydrolipoic acid, could regenerate Fe2+ to further boost the ferroptosis. The results disclosed that T10@cLAV achieved tumor inhibition comparable to that of cisplatin at a dose as low as 5 mg/kg in the HeLa tumor-bearing nude mice model and caused no toxicity at the dose up to 300 mg/kg. This tactful iron-supplement strategy of hijacking blood Tf is superior to the current strategies: one is the induction of intracellular ferritin degradation, which is limited by the low content of ferritin, and the other is the delivery of iron-based materials, which easily causes adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNanoparticlesNeoplasmsMiceAnimalsTransferrinMice, NudeIronFerritins

Substanzen

TransferrinIronFerritins

Autor:innen und Institutionen

  • College of Biomedical Engineering and National Engineering Research Center for Biomaterials, Sichuan University, 610064 Chengdu, China.

ORCID-Profile: Shiyong Zhang

Förderung

  • National Natural Science Foundation of China
  • Sichuan Science and Technology Innovation Foundation

Zitieren

APA

Zhang, S., Wu, X., Liao, X., & Zhang, S. (2024). Nanodrug Hijacking Blood Transferrin for Ferroptosis-Mediated Cancer Treatment. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c00395

Vancouver

Zhang S, Wu X, Liao X, Zhang S. Nanodrug Hijacking Blood Transferrin for Ferroptosis-Mediated Cancer Treatment. Journal of the American Chemical Society. 2024. doi:10.1021/jacs.4c00395

BibTeX
@article{Zhang2024,
  author = {Zhang, Shuyue and Wu, Xiao and Liao, Xiaoming and Zhang, Shiyong},
  title = {Nanodrug Hijacking Blood Transferrin for Ferroptosis-Mediated Cancer Treatment},
  journal = {Journal of the American Chemical Society},
  year = {2024},
  doi = {10.1021/jacs.4c00395}
}
Kostenlos starten →